Correlation Between CorMedix and Sangamo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CorMedix and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CorMedix and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CorMedix and Sangamo Therapeutics, you can compare the effects of market volatilities on CorMedix and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CorMedix with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CorMedix and Sangamo Therapeutics.

Diversification Opportunities for CorMedix and Sangamo Therapeutics

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between CorMedix and Sangamo is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding CorMedix and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and CorMedix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CorMedix are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of CorMedix i.e., CorMedix and Sangamo Therapeutics go up and down completely randomly.

Pair Corralation between CorMedix and Sangamo Therapeutics

Given the investment horizon of 90 days CorMedix is expected to under-perform the Sangamo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, CorMedix is 1.11 times less risky than Sangamo Therapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The Sangamo Therapeutics is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest  113.00  in Sangamo Therapeutics on November 29, 2024 and sell it today you would lose (15.00) from holding Sangamo Therapeutics or give up 13.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

CorMedix  vs.  Sangamo Therapeutics

 Performance 
       Timeline  
CorMedix 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CorMedix are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain primary indicators, CorMedix exhibited solid returns over the last few months and may actually be approaching a breakup point.
Sangamo Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Sangamo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

CorMedix and Sangamo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CorMedix and Sangamo Therapeutics

The main advantage of trading using opposite CorMedix and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CorMedix position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.
The idea behind CorMedix and Sangamo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years